title: Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.
abstract: Two classes of enzymes play an important role in connective tissue breakdown during various inflammatory diseases: serine proteinases and matrix metalloproteinases (MMPs). Tetracyclines (TCs) exhibit important anti-inflammatory and MMP-inhibitory properties that are unrelated to their antibacterial activities. Of the various TCs and their chemically modified NON-antibiotic analogs (CMTs) tested in vitro and in vivo, CMT-3 (6-demethyl-6-deoxy 4 de-dimethylamino tetracycline) has repeatedly been shown to be the most potent inhibitor of MMP activity and cytokine production. In addition to its anti-MMP function, we have shown that among all CMTs, CMT-3 is the only CMT that can also directly inhibit both the amidolytic activity of human leukocyte elastase (HLE, a serine proteinase) and the extracellular matrix degradation mediated by HLE. In addition, CMT-3 has been found to reduce leukocyte elastase activity in vivo in gingival extracts of rats with experimental periodontal disease. Thus, CMT-3 can inhibit pathologic connective tissue breakdown by (at least) two mechanisms: direct inhibition of neutral proteinases (elastase and MMPs); and protecting their endogenous inhibitors, α(1)-PI and TIMPs, from being digested and inactivated by MMPs and HLE, respectively. The pleiotropic properties of CMT-3 including (but not limited to) inhibition of serine proteinases, MMPs, and cytokines provide impressive therapeutic potential to reduce excessive connective tissue breakdown during various pathologic processes including inflammatory diseases, cancer metastasis and metabolic bone diseases.
authors.affiliation: Department of General Dentistry, School of Dental Medicine, Stony Brook University, Stony Brook, NY 11794-8706, United States. ying.gu@stonybrook.edu
authors.forename: Ying
authors.initials: Y
authors.lastname: Gu
authors.forename: Hsi-Ming
authors.initials: HM
authors.lastname: Lee
authors.forename: Sanford R
authors.initials: SR
authors.lastname: Simon
authors.forename: Lorne M
authors.initials: LM
authors.lastname: Golub
mesh_terms: D000818:Animals; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013754:Tetracyclines / Q000494:pharmacology*
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D015842:Serine Proteinase Inhibitors; D013754:Tetracyclines; C117155:tetracycline CMT-3; D010196:Pancreatic Elastase